Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis.
Claudia Asenjo-LobosLeticia GonzálezJuan Francisco BulnesMarta RoquePaula Muñoz VenturelliGonzalo Martínez RodríguezPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
Patients with SAD present an increased risk of CV morbidity and mortality, which should be considered when establishing therapeutic strategies. These findings support the role of systemic inflammation in the development of atherosclerosis-driven disease.